Abl-interactor-1, a novel SH3 protein binding to the carboxy-terminal portion of the Abl protein, suppresses v-abl transforming activity.
Tóm tắt
Từ khóa
Tài liệu tham khảo
1970, Influence of prednisolone on Moloney leukemogenic virus in BALB/c mice, Cancer Res., 30, 2208
1970, Lymphosarcoma: Virus-induced thymic-independent disease in mice., Cancer Res., 30, 2213
Ausubel, F.M., R. Brent, R.E. Kingston, D.D. Moore, J.G. Seidman, J.A. Smith, and K. Struhl. 1987. Current protocols in molecular biology. John Wiley/Greene, New York.
1987, Nucleic acid sequence and oncogenic properties of the HZ2 Feline sarcoma virus v-abl insert., J. Virol., 61, 1193, 10.1128/jvi.61.4.1193-1202.1987
1988, Primary structure and developmental expression pattern of Hox3.1, a member of the murine Hox3 homeobox gene cluster., EMBO J., 7, 1329, 10.1002/j.1460-2075.1988.tb02948.x
1987, High-efficiency transformation of mammalian cells by plasmid DNA., Mol. Cell. Biol., 7, 2745
Dai, Z. and A.M. Pendergast. 1995. Aip-1, a novel SH3-containing nuclear protein is a substrate of the c-abl tyrosine kinase (this issue).
1994, c-Abl kinase regulates the protein binding activity of c-Crk., EMBO J., 13, 2341, 10.1002/j.1460-2075.1994.tb06518.x
1989, Deletion of an N-terminal regulatory domain of the c-abl tyrosine kinase activates its oncogenic potential., EMBO J., 8, 137, 10.1002/j.1460-2075.1989.tb03358.x
1981, Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase., J. Virol., 38, 239, 10.1128/jvi.38.1.239-248.1981
1981, Genome structure of Abelson murine leukemia virus variants: Proviruses in fibroblasts and lymphoid cells., J. Virol., 38, 460, 10.1128/jvi.38.2.460-468.1981
1993, Oncogenic activation of c-ABL by mutation within its last exon., Mol. Cell. Biol., 13, 4967
1992, Bone marrow-transforming activity of linker insertion mutants of Abelson murine leukemia virus., Oncogene, 7, 2323
1993, Transforming activity and tissue tropism of hybrid retroviral genomes containing portions of the v-abl and v-src oncogenes., Oncogene, 8, 2413
1989, N-terminal mutations activate the leukemogenic potential of the myristylated form of c-abl., EMBO J., 8, 449, 10.1002/j.1460-2075.1989.tb03397.x
1993, Mutation of a phenylalanine conserved in SH3-containing tyrosine kinases activates the transforming ability of c-Abl., Oncogene, 8, 1943
1994, Cloning and functional expression of the mouse homologue of p47phox., Immunogenetics, 39, 272
1989, Vav, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells., EMBO J., 8, 2283, 10.1002/j.1460-2075.1989.tb08354.x
1992, Genetic assay for multimerization of retroviral gag polyproteins., J. Virol., 66, 5157, 10.1128/jvi.66.8.5157-5160.1992
Maniatis, T., E.F. Fristch, and J. Sambrook. 1982. Molecular cloning: A laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York.
1994, Mutagenic analysis of the roles of SH2 and SH3 domains in regulation of the Abl tyrosine kinase., Mol. Cell. Biol., 14, 2883
1992, Point mutations in the Abl SH2 domain coordinately impair phosphotyrosine binding in vitro and transforming activity in vivo., Mol. Cell. Biol., 12, 609
1993, An actin-binding function contributes to transformation by the Bcr-Abl oncoprotein of Philadelphia chromosome-positive human leukemias., EMBO J., 12, 1533, 10.1002/j.1460-2075.1993.tb05797.x
1994, The protein tyrosine kinase substrate cortactin is differentially expressed in murine B lymphoid tumors., Oncogene, 9, 1989
1991, BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias., Mol. Cell. Biol., 11, 1785
1986, Abelson murine leukemia virus variants with increased oncogenic potential., J. Virol., 60, 599, 10.1128/jvi.60.2.599-606.1986
1994, Identification of CRKL as the constitutively phosphorylated 39-kD tyrosine phosphoprotein in chronic myelogenous leukemia cells., Blood, 84, 2912, 10.1182/blood.V84.9.2912.2912
1991, Carboxyl-terminal determinants of Abelson protein important for lymphoma induction., J. Virol., 65, 6478, 10.1128/jvi.65.12.6478-6485.1991
1992, Oncogenic v-abl tyrosine kinase can inhibit or stimulate growth, depending on the cell context., EMBO J., 11, 3941, 10.1002/j.1460-2075.1992.tb05488.x
1992, Comparison of mouse and human Hox4.4 complexes defines conserved sequences involved in the regulation of Hox4.4., EMBO J., 11, 1459, 10.1002/j.1460-2075.1992.tb05190.x
1994, Abl-mediated transformation, immunoglobulin gene rearrangements and arrest of B lymphocyte differentiation., Semin. Cancer Biol., 5, 95
1980, Abelson leukemia virus mutants with alterations in virus-specific P120 molecule., J. Virol., 33, 340, 10.1128/jvi.33.1.340-348.1980
1980, Abelson murine leukemia virus mutants deficient in kinase activity and lymphoid cell transformation., J. Virol., 36, 766, 10.1128/jvi.36.3.766-774.1980
1993, Rearrangements involving chromosome band 11Q23 in acute leukaemia., Semin. Cancer Biol., 4, 377
1994, G1 cyclin degradation: The PEST motif of yeast cln2 is necessary but not sufficient for rapid protein turnover., Mol. Cell. Biol., 14, 7953
1993, The role of myc in transformation by BCR-ABL., Leuk. Lymphoma, 1, 45
1993, The product of the EMS1 gene, amplified and overexpressed in human carcinomas, is homologous to a v-src substrate and is located in cell-substratum contact sites., Mol. Cell. Biol., 13, 2891
1993, Abl tyrosine kinase in signal transduction and cell-cycle regulation., Curr. Opin. Genet. Dev., 3, 35, 10.1016/S0959-437X(05)80338-7
1983, Site-directed deletions of Abelson murine leukemia virus define 3′ sequences essential for transformation and lethality., J. Virol., 45, 1028, 10.1128/jvi.45.3.1028-1036.1983